Why the study?
Does EDTA chelation therapy improve time to ischemia and quality of life in patients with stable ischemic heart disease?
Population
n=84 adults with stable ischemic heart disease and stable angina while receiving optimal medical therapy…
Comparison
Weight-adjusted EDTA chelation therapy infusion… vs Placebo infusion for 3 hours per treatment…
Design
RCT, Randomly assigned, Double-blind, placebo-controlled
Follow-up
27 weeks
Authors
Loading...
EDTA chelation shows no benefit in stable ischemic heart disease; confirms lack of efficacy and advises against clinical use.
Does EDTA chelation therapy improve time to ischemia and quality of life in patients with stable ischemic heart disease?
EDTA chelation therapy does not improve exercise time to ischemia, exercise capacity, or quality of life in patients with stable ischemic heart disease compared to placebo.
Merril L. Knudtson (2002) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: